Rznomics Inc. Stock Price

KOSDAQ:A476830 Community·₩2.2t Market Cap

0 Narratives written by author
0 Comments on narratives written by author
0 Fair Values set on narratives written by author

Create a narrative

A476830 Share Price Performance

₩160,500.00

70500.00 (78.33%)

₩160,500.00

70500.00 (78.33%)

₩160,500.00

Wed, 31 Dec 25

Share Pricen/a

A476830 Community Narratives

There are no narratives available yet.

Create a narrative

There are no community narratives available.

Trending Discussion

Snowflake Analysis

Very low risk with weak fundamentals.

2 Risks

0 Rewards

View Full Analysis

Rznomics Inc. Key Details

Last Reported Earnings

n/a

Next Reporting Earnings

n/a

: 0
: 0%
: 0%
: 0%

View Full Analysis

About A476830

Founded: 2017
Employees: n/a
CEO: Lee Seong-wook
WebsiteView website: www.rznomics.com

Rznomics Inc. develops RNA based gene therapies for cancers and intractable diseases. Its development stage product candidates include RZ-001_immune therapy combination product, which is in Phase 1b/2a stage for treating Hepatocellular carcinoma; RZ-001 (GBM) that is in Phase 1/2a stage for Glioblastoma; RZ-003, which is in discovery stage for Alzheimer; RZ-004, a pre-clinical product for Retinitis Pigmentosa; and RZ-005, a discovery stage product to treat Rett Syndrome. Rznomics Inc. was incorporated in 2017 and is head quartered in Seongnam, South Korea.